These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22843627)

  • 1. Surveillance on interfacility differences in dose-prescription policy of intensity-modulated radiation therapy plans for prostate cancer.
    Mizowaki T; Hatano K; Hiraoka M
    J Radiat Res; 2012 Jul; 53(4):608-14. PubMed ID: 22843627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards automated on-line adaptation of 2-Step IMRT plans: QUASIMODO phantom and prostate cancer cases.
    Holubyev K; Bratengeier K; Gainey M; Polat B; Flentje M
    Radiat Oncol; 2013 Nov; 8():263. PubMed ID: 24207129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.
    Reddy NM; Nori D; Chang H; Lange CS; Ravi A
    Med Phys; 2010 Jul; 37(7):3791-801. PubMed ID: 20831087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intensity-modulated radiotherapy and forward-planning dynamic arc therapy techniques for prostate cancer.
    Metwaly M; Awaad AM; El-Sayed EM; Sallam ASM
    J Appl Clin Med Phys; 2008 Oct; 9(4):37-56. PubMed ID: 19020481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of the impact of systematic uncertainties in patient setup and prostate motion on doses to the target among different plans for definitive external-beam radiotherapy for prostate cancer.
    Zhu SY; Mizowaki T; Norihisa Y; Takayama K; Nagata Y; Hiraoka M
    Int J Clin Oncol; 2008 Feb; 13(1):54-61. PubMed ID: 18307020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.
    Martinez AA; Yan D; Lockman D; Brabbins D; Kota K; Sharpe M; Jaffray DA; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1226-34. PubMed ID: 11483333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
    Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
    Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
    [No Abstract]   [Full Text] [Related]  

  • 9. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
    Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
    Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.
    Wang L; Movsas B; Jacob R; Fourkal E; Chen L; Price R; Feigenberg S; Konski A; Pollack A; Ma C
    J Appl Clin Med Phys; 2004; 5(2):29-41. PubMed ID: 15738911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing.
    Dogan N; King S; Emami B; Mohideen N; Mirkovic N; Leybovich LB; Sethi A
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1480-91. PubMed ID: 14630288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study.
    Soda R; Hatanaka S; Hariu M; Shimbo M; Yamano T; Nishimura K; Kondo S; Utsumi N; Takahashi T
    J Xray Sci Technol; 2020; 28(2):243-254. PubMed ID: 31985486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative study of IMRT delivery effects in commercial planning systems for the case of oesophagus and prostate tumours.
    Seco J; Clark CH; Evans PM; Webb S
    Br J Radiol; 2006 May; 79(941):401-8. PubMed ID: 16632620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary Relation Between the Improvement of Dose Delivery Technique and PTV Margin Reduction in Dose-Escalated Radiation Therapy for Prostate Cancer.
    Utsunomiya S; Yamamoto J; Tanabe S; Oishi M; Satsuma A; Kaidu M; Abe E; Ohta A; Kushima N; Aoyama H
    Pract Radiat Oncol; 2019 May; 9(3):172-178. PubMed ID: 30772440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a simultaneous boost IMRT class solution for a hypofractionated prostate cancer protocol.
    Mott JH; Livsey JE; Logue JP
    Br J Radiol; 2004 May; 77(917):377-86. PubMed ID: 15121701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
    Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.